You are here

Roche to pay more than US$1b for majority stake in tumour-testing company

156481133.jpg
The Swiss pharmaceutical giant Roche said on Monday that it would acquire a majority of the tumour-testing company Foundation Medicine for more than US$1 billion, in a deal aimed at improving both cancer treatment and drug development.

New York

THE Swiss pharmaceutical giant Roche said on Monday that it would acquire a majority of the tumour-testing company Foundation Medicine for more than US$1 billion, in a deal aimed at improving both cancer treatment and drug development.

Foundation is the leader in the

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom